{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:55Z","timestamp":1793371015579,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.08.103","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:30:06Z","timestamp":1788190206000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When \u201cmild\u201d psoriasis is not mild: Ethical treatment eligibility for low-body surface area, high-impact-site disease"],"prefix":"10.1016","author":[{"given":"Rahib K.","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2026.08.103_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/bjd\/ljaf404","article-title":"Psoriasis at high-impact sites: shifting the paradigm","volume":"194","author":"Tsakok","year":"2026","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.08.103_bib2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s13555-025-01456-5","article-title":"Patient-reported outcomes by baseline body surface area involvement among individuals initiating biologic therapy: results from the CorEvitas Psoriasis Registry","volume":"15","author":"Armstrong","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.103_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","article-title":"Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council","volume":"82","author":"Strober","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.103_bib4","first-page":"372","article-title":"Establishing consensus on defining failure of topical therapy in psoriasis: recommendations from the International Psoriasis Council","volume":"94","author":"Strober","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.103_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s13555-025-01393-3","article-title":"Management of challenging psoriasis clinical scenarios","volume":"15","author":"Stein Gold","year":"2025","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226034481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226034481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:27:36Z","timestamp":1793370456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226034481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"alternative-id":["S0190962226034481"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.103","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When \u201cmild\u201d psoriasis is not mild: Ethical treatment eligibility for low-body surface area, high-impact-site disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}